These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34313404)

  • 1. Random control selection for conducting high-throughput adverse drug events screening using large-scale longitudinal health data.
    Chiang CW; Zhang P; Donneyong M; Chen Y; Su Y; Li L
    CPT Pharmacometrics Syst Pharmacol; 2021 Sep; 10(9):1032-1042. PubMed ID: 34313404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A data-driven method to detect adverse drug events from prescription data.
    Zhan C; Roughead E; Liu L; Pratt N; Li J
    J Biomed Inform; 2018 Sep; 85():10-20. PubMed ID: 30016721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
    Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
    Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting potential signals of adverse drug events from prescription data.
    Zhan C; Roughead E; Liu L; Pratt N; Li J
    Artif Intell Med; 2020 Apr; 104():101839. PubMed ID: 32499007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing a clinical pharmacy survey of adverse drug events in a French emergency department.
    Roulet L; Asseray N; Dary M; Chiffoleau A; Potel G; Ballereau F
    Int J Clin Pharm; 2012 Dec; 34(6):902-10. PubMed ID: 22923368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a Bioinformatics-Based Toxicity Scoring System to Assess Serotonin Burden and Predict Population-Level Adverse Drug Events from Concomitant Serotonergic Drug Therapy.
    Culbertson VL; Rahman SE; Bosen GC; Caylor ML; Xu D
    Pharmacotherapy; 2019 Feb; 39(2):171-181. PubMed ID: 30620414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SSEL-ADE: A semi-supervised ensemble learning framework for extracting adverse drug events from social media.
    Liu J; Zhao S; Wang G
    Artif Intell Med; 2018 Jan; 84():34-49. PubMed ID: 29111222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine use of the "ADE scorecards", an application for automated ADE detection in a general hospital.
    Chazard E; Luyckx M; Beuscart JB; Ferret L; Beuscart R
    Stud Health Technol Inform; 2013; 192():308-12. PubMed ID: 23920566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital admissions caused by adverse drug events: an Australian prospective study.
    Phillips AL; Nigro O; Macolino KA; Scarborough KC; Doecke CJ; Angley MT; Shakib S
    Aust Health Rev; 2014 Feb; 38(1):51-7. PubMed ID: 24351707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance and predictive value of two adverse drug event data sets.
    Cami A; Reis BY
    BMC Med Inform Decis Mak; 2014 Aug; 14():74. PubMed ID: 25149292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study.
    de Vries ST; Haaijer-Ruskamp FM; de Zeeuw D; Denig P
    Health Qual Life Outcomes; 2014 Aug; 12():103. PubMed ID: 25115618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical prediction rule to identify high-risk inpatients for adverse drug events: the JADE Study.
    Sakuma M; Bates DW; Morimoto T
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1221-6. PubMed ID: 22887972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceived barriers to reporting adverse drug events in hospitals: a qualitative study using theoretical domains framework approach.
    Mirbaha F; Shalviri G; Yazdizadeh B; Gholami K; Majdzadeh R
    Implement Sci; 2015 Aug; 10():110. PubMed ID: 26250159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of adverse drug event information in US manufacturer labels.
    Harrington CA; Garcia AS; Sircar-Ramsewak F
    Curr Drug Saf; 2011 Feb; 6(1):30-5. PubMed ID: 21047299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy.
    Klopotowska JE; Wierenga PC; Stuijt CC; Arisz L; Dijkgraaf MG; Kuks PF; Asscheman H; de Rooij SE; Lie-A-Huen L; Smorenburg SM;
    PLoS One; 2013; 8(8):e71045. PubMed ID: 23940688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a computerized drug-monitoring program to detect and prevent adverse drug events and medication non-adherence in outpatient ambulatory care: study protocol of a randomized controlled trial.
    Forster AJ; Erlanger TE; Jennings A; Auger C; Buckeridge D; van Walraven C; Tamblyn R
    Trials; 2015 Jan; 16():2. PubMed ID: 25572800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building a knowledge base of severe adverse drug events based on AERS reporting data using semantic web technologies.
    Jiang G; Wang L; Liu H; Solbrig HR; Chute CG
    Stud Health Technol Inform; 2013; 192():496-500. PubMed ID: 23920604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a computer-based adverse-drug-event monitor.
    Hwang SH; Lee S; Koo HK; Kim Y
    Am J Health Syst Pharm; 2008 Dec; 65(23):2265-72. PubMed ID: 19020194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group.
    Bates DW; Miller EB; Cullen DJ; Burdick L; Williams L; Laird N; Petersen LA; Small SD; Sweitzer BJ; Vander Vliet M; Leape LL
    Arch Intern Med; 1999 Nov; 159(21):2553-60. PubMed ID: 10573045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.